Funding for this research was provided by:
National Human Genome Research Institute (UM1 HG006493)
National Heart, Lung, and Blood Institute (U24 HG008956)
Received: 6 March 2020
Accepted: 6 October 2020
First Online: 16 October 2020
Ethics approval and consent to participate
: The study was approved by the Institutional Review Board of Seattle Children’s Hospital and separately approved by the University of Washington Human Subjects Review Committee.
: Obtained with research protocol for Seattle Children’s Hospital Immunology Biorepository.
: The authors declare that they have no competing interests.